CCDC144CP

Across TCGA pan-cancer cohorts, CCDC144CP Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CCDC144CP data layer compared with 24 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher CCDC144CP Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CCDC144CP expression acts as an unfavorable survival marker.

BLCA and ESCA are the cancer types where CCDC144CP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.254	0.610	.031	12	view →
ESCA	DFS	Median	II,III,IV	0.082	0.523	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CCDC144CP–BLCA (OS)

Open the BLCA breakdown →